openPR Logo
Press release

Myocardial Infarction Treatment Market Intelligence with Competitive Landscape 2023

10-09-2017 04:33 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Transparency Market Research

/ PR Agency: Transparency Market Research
Myocardial Infarction Treatment Market Intelligence with

Myocardial infarction or heart attack is an irreversible acute medical condition, which leads to the necrosis of heart muscles secondary to extended ischemia. Myocardial infarction occurs when a part of heart is deprived of oxygen, which is caused due to the blockage of one of the coronary arteries. Usually blockage is developed due to the buildup of atherosclerotic plaque on the walls of arteries. In most of the cases, myocardial infarctions are located in the septal, anterior, posterior, lateral or inferior walls of the left ventricle of the heart. Thus, lack of oxygen causes distinctive pain in the chest and death of myocardial tissue, which leads to myocardial infarction in humans. 

Request Sample Copy of the Report@

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=8215 

 

Some of the medications usually used for the treatment of myocardial infarction are as follows:

Antiplatelet agents
Aspirin
Vorapaxar
Clopidogrel
Glycoprotein IIb/IIIa inhibitors
Abciximab
Tirofiban
Eptifibatide
Antithrombotic agents
Heparin
Bivalirudin
Enoxaparin
Beta-adrenergic blockers
Metoprolol
Esmolol
Vasodilators
Nitroglycerin
Angiotensin-Converting Enzyme (ACE) inhibitors
Enalapril
Captopril
Lisinopril
Angiotensin-Receptor blockers
Candesartan
Valsartan
Analgesics
Morphine sulfate
Thrombolytics
Tenecteplase
Alteplase (t-PA) 
In terms of geography, North America is the largest market for myocardial infarction treatment market due to high incidence and prevalence rate of cardiac diseases coupled with increasing base of obese population. According to the Centers for Disease Control and Prevention (CDC), approximately 600,000 people in the U.S. die of heart disease annually. The organization also claims that annually the U.S. spends around USD 108.9 billion on treatment and management of coronary heart diseases. Moreover, according to the Heart Foundation, by the end of 2014, approximately 920,000 people in the U.S. will have a heart attack. Thus, this large base of heart patients is expected to drive the market growth of myocardial infarction treatment in this region. However, other regions such as South East Asia, Middle East and Latin America are expected to be the prospective market in the future. Owing to the high incidence rate of heart diseases and high adoption rate for advanced therapeutics, these regions are expected to be the potential market in the near future. 

Overall, the myocardial infarction treatment market is witnessing an admirable growth due to the rising incidence rate of cardiovascular diseases and increasing base of geriatric population. Moreover, other factors that are contributing to the growth of this market are high incidence rate of obesity along with chronic diseases such as diabetes, hypertension and chronic kidney diseases. Furthermore, unhealthy lifestyle practices, excessive alcohol consumption and use of drugs such as amphetamines and cocaine, among population are the important risk factors for myocardial infarction; alternatively, which would boosts the growth of myocardial infarction treatment and management products in the near future. It has also been estimated that, the global myocardial infarction treatment market shows potential to be a lucrative and expanding field due the increasing adoption rate for effective and safe treatment regimens. Expected technological breakthroughs will generate abundant opportunities for detecting targeted blockages, monitoring cellular response and for determining genetic predisposition, which might alternatively drive the growth of the myocardial infarction treatment market. However, rise in overall healthcare expenditure, stringent regulatory policies and high costs of clinical trials are some of the market-restraining factors that might impede the growth of myocardial infarction treatment market in the near future.

At present, the myocardial infarction treatment market is a highly fragmented and established market owing to the involvement of many recognized as well as emerging players in this industry. However, it has been estimated that in the near future new entrants will try to invade this industry due to the high incidence and prevalence rate of acute myocardial infarction and other cardiovascular diseases. Some of the major players involved in this market are Bayer HealthCare LLC, Daiichi Sankyo, Inc., Eli Lilly and Company, Janssen Biotech, Inc., Merck & Co. Inc., Novartis International AG and Sanofi amongst others. 

Request TOC of the Report@

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=8215 

 

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Myocardial Infarction Treatment Market Intelligence with Competitive Landscape 2023 here

News-ID: 763625 • Views: 159

More Releases from Transparency Market Research

Electromechanical Microwave Switch Market To receive overwhelming hike in Revenu …
Transparency Market Research delivers key insights on the global electromechanical microwave switch market. Get Report Details- https://www.transparencymarketresearch.com/electromechanical-microwave-switch-market.html In terms of revenue, the global electromechanical microwave switch market is estimated to expand at a CAGR of ~5% during the forecast period, owing to numerous factors, regarding which TMR offers thorough insights and forecasts in its report on the global electromechanical microwave switch market. Grab an Exclusive PDF Sample of this Report -https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=82213 Electromechanical Microwave
Emerging trends of the High Reliability Semiconductor Market 2021-2031
Transparency Market Research delivers key insights on the global high reliability semiconductor market. In terms of revenue, the global high reliability semiconductor market is extended to expand at a CAGR of ~5% during the forecast period, owing to numerous factors regarding which TMR offers thorough insights and forecasts in its report on the global high reliability semiconductor market. Get Report Details- https://www.transparencymarketresearch.com/high-reliability-semiconductors-market.html The global high reliability semiconductor market is broadly affected by
DUV Lithography Systems Market Pegged for Robust Expansion During 2021-2031
The COVID-19 crisis has led to a shortage of semiconductor products, owing to a slowdown in production activities. Nevertheless, changing consumer habits are grabbing the attention of companies in the DUV lithography systems market, pertaining to the demand for gaming consoles, TVs, and 5G-enabled smartphones, among others. Get More Report Details- https://www.transparencymarketresearch.com/duv-lithography-systems-market.html On the other hand, the electrification of vehicles is anticipated to generate great future revenue opportunities for manufacturers in the
Electronic Potting & Encapsulating Market To Register Substantial Expansion By 2 …
Potting is the process of filling a complete electronic assembly with a solid or gelatinous compound such as acrylic, silicone, or resins. Potting provides resistance to vibration and shocks. It also offers protection from corrosive agents and moisture. Report Details- https://www.transparencymarketresearch.com/electronic-potting-encapsulating-market.html Encapsulation forms a frame around an object and fills the space between the frame and the object with compounds by using a reusable mold. The key purpose of encapsulation is to

All 5 Releases


More Releases for Myocardial

Post-Myocardial Infarction Market rake higher revenue in 2025
Global Post-Myocardial Infarction Market: Overview The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are
Post-Myocardial Infarction Market Discerning new trends 2025
Global Post-Myocardial Infarction Market: Overview The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are
Myocardial Ischemia Market to Record Ascending Growth
Myocardial ischemia is characterized by a specific condition, where there is an insufficient flow of blood to the heart muscle (myocardium) through coronary arteries. Due to an obstruction or constriction of the arteries, the heart is not able to pump oxygenated blood and other vital nutrients to the body efficiently and finally leads to destruction of the heart muscles. Blockage of an artery (due to atherosclerotic plaque), blood clots, heart
Post-Myocardial Infarction Market - Vendor Landscape & Forecast 2017 - 2025
Global Post-Myocardial Infarction Market: Overview The most common term used to refer to myocardial infarction is heart-attack. In this report, Transparency Market Research (TMR) delves into studying the factors causing the demand for post-myocardial infarction treatment. For the purpose of the study, TMR thus segments the global post-myocardial infarction market based on various parameters and then identifies opportunities prevalent across each of these segments. Besides this, the potential market threats are
Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023
"The Report Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" ​DelveInsights Myocardial Infarction - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Myocardial Infarction for the seven major markets i.e. United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. Get
Myocardial Ischemia - Pipeline Review, H1 2017
MarketResearchReports.Biz presents this most up-to-date research on "Myocardial Ischemia - Pipeline Review, H1 2017" Description Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocardial Ischemia - Pipeline Review, H1 2017, provides an overview of the Myocardial Ischemia (Cardiovascular) pipeline landscape. Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side